Ingenium Therapeutics announced that it has raised KRW 5,300 million in a round of funding on November 21, 2023. The transaction included participation from new investors Capstone Partners Co., Ltd.,KGROUND Ventures LLC,Laplace Partners Inc. and Daewoodang Healthcare.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,735 KRW | -4.96% |
|
-8.23% | -28.17% |
1st Jan change | Capi. | |
---|---|---|
-28.17% | 38.38M | |
+20.22% | 3.2B | |
+12.50% | 1.76B | |
+12.54% | 1.59B | |
-11.54% | 1.22B | |
+34.19% | 906M | |
+7.25% | 650M | |
+53.93% | 603M | |
-4.78% | 504M | |
+19.25% | 435M |
- Stock Market
- Equities
- A452300 Stock
- News Capstone Partners Co., Ltd.
- Ingenium Therapeutics announced that it has received KRW 5.3 billion in funding from Laplace Partners Inc., Capstone Partners Co., Ltd., KGROUND Ventures LLC and another investor.